GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
GenMark Diagnostics, Inc (GNMK) [hlAlert]

Rating:
Outperform
GNMK
down 5.79 %

GenMark Diagnostics, Inc (GNMK) rated Outperform by Raymond James

Posted on: Friday,  Dec 21, 2012  11:25 AM ET by Raymond James

Raymond James rated Outperform GenMark Diagnostics, Inc (NASDAQ: GNMK) on 12/21/2012, when the stock price was $10.01. Since
then, GenMark Diagnostics, Inc has lost 5.79% as of 09/16/2015's recent price of $9.43.
If you would have followed this Raymond James's recommendation on GNMK, you would have lost 5.79% of your investment in 999 days.

GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company?s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.

Our equity research team has gained national attention for stock-picking ability and analyst performance, with recognition in leading publications such as the Wall Street Journal and Institutional Investor magazine*. Raymond James’ equity research philosophy focuses on a fundamental approach that encompasses three basic points. First, we believe that superior research on select companies within well-defined industries is preferable to broad general coverage. Second, we concentrate on the identification of quality companies demonstrating solid growth potential, with the goal of helping our clients maximize their investment returns. Third, to help our clients take advantage of pockets of inefficiency in the market, we strive to locate superior companies from across the country that have the potential to provide our clients with unique opportunities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/21/2012 11:25 AM Buy
None
10.01
as of 12/31/2012
1 Week down  -9.54 %
1 Month down  -10.08 %
3 Months   
1 YTD down  -10.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy